Not applicableStudy completedNCT04837651
What this trial is testing
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
Who this might be right for
Multiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous System+5 more
Dragonfly Research, LLC 48